Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glutamate Receptor”

51 trials

Showing 20 of 51 results

Testing effectiveness (Phase 2)Study completedNCT01482221
What this trial is testing

Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 542
Not applicableStudy completedNCT00662571
What this trial is testing

Acamprosate: Genes Associated With Response

Who this might be right for
Alcoholism
Mayo Clinic 485
Large-scale testing (Phase 3)Study completedNCT02967640
What this trial is testing

Does Subacromial Injection With Glutamate Receptor Antagonist, Ketamine, Attenuate Pain in Rotator Cuff Tendinopathy?

Who this might be right for
Rotator Cuff TendinitisChronic Pain
Helse Møre og Romsdal HF 14
Early research (Phase 1)Study completedNCT02769936
What this trial is testing

Glutamate, Learning, and Working Memory

Who this might be right for
Schizophrenia
University of California, Los Angeles 110
Large-scale testing (Phase 3)Study completedNCT04019704
What this trial is testing

A Trial of AXS-05 in Patients With Major Depressive Disorder

Who this might be right for
DepressionMajor Depressive Disorder
Axsome Therapeutics, Inc. 327
Testing effectiveness (Phase 2)Study completedNCT01882829
What this trial is testing

Nuedexta in Treatment-Resistant Major Depression

Who this might be right for
Major Depressive DisorderTreatment Resistant
James Murrough 20
Testing effectiveness (Phase 2)Study completedNCT00001365
What this trial is testing

Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

Who this might be right for
Neurodegenerative DiseaseParkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 42
Large-scale testing (Phase 3)WithdrawnNCT03115489
What this trial is testing

Efficacy of Ketamine Infusion Compared With Traditional Anti-epileptic Agents in Refractory Status Epilepticus

Who this might be right for
Refractory Epilepsy
University of Alabama at Birmingham
Not applicableStudy completedNCT02094196
What this trial is testing

The Role of Dopaminergic and Glutamatergic Neurotransmission for Dysfunctional Learning in Alcohol Use Disorders

Who this might be right for
Alcohol Use Disorder
Technische Universität Dresden 60
Large-scale testing (Phase 3)Study completedNCT00000371
What this trial is testing

Trial of D-Cycloserine in Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital 60
Early research (Phase 1)Ended earlyNCT04618263
What this trial is testing

Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers

Who this might be right for
Major Depressive DisorderExcessive Sleepiness
Syndeio Biosciences, Inc 18
Testing effectiveness (Phase 2)Study completedNCT00001930
What this trial is testing

Treatment of Huntington's Chorea With Amantadine

Who this might be right for
ChoreaHuntington's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25
Not applicableStudy completedNCT02236897
What this trial is testing

PET Imaging in ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Johns Hopkins University 36
Not applicableStudy completedNCT00042523
What this trial is testing

Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 61
Testing effectiveness (Phase 2)Ended earlyNCT04821271
What this trial is testing

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Who this might be right for
Major Depressive DisorderTreatment-Resistant DepressionDepression
National Institute of Mental Health (NIMH) 11
Early research (Phase 1)Ended earlyNCT02108015
What this trial is testing

Evaluation of a Novel Positron Emission Tomography (PET Radiotracer for TARP Gamma-8

Who this might be right for
Healthy Volunteers
National Institute of Mental Health (NIMH) 6
Early research (Phase 1)Study completedNCT06273540
What this trial is testing

Phase1, STP7 Cocaine Drug-Drug Interaction Study

Who this might be right for
Cocaine Use Disorder
Stalicla SA 21
Not applicableUnknownNCT00317668
What this trial is testing

Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients

Who this might be right for
Epilepsy
Hadassah Medical Organization 250
Not applicableUnknownNCT05340660
What this trial is testing

MGluR5 Imaging in ALS Using PET

Who this might be right for
Amyotrophic Lateral Sclerosis
Nathalie Braun 30
Not applicableUnknownNCT03998787
What this trial is testing

Metabotropic Receptors For Glutamate Type 3 In Parkinson's

Who this might be right for
NeuroscienceMovement Disorders
Neuromed IRCCS 40
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation